subutex 0,4 mg sublingualtabletten
indivior schweiz ag - buprenorphinum - sublingualtabletten - buprenorphinum 0.4 mg ut buprenorphini hydrochloridum, lactosum monohydricum corresp. lactosum 28.143 mg, mannitolum, maydis amylum, povidonum k 30, acidum citricum, natrii citras dihydricus corresp. natrium 0.036 mg, magnesii stearas, pro compresso. - substitution en cas de dépendance aux opiacés - synthetika
subutex 2 mg sublingualtabletten
indivior schweiz ag - buprenorphinum - sublingualtabletten - buprenorphinum 2 mg ut buprenorphini hydrochloridum, lactosum monohydricum corresp. lactosum 45.541 mg, mannitolum, maydis amylum, povidonum k 30, acidum citricum, natrii citras dihydricus corresp. natrium 0.06 mg, magnesii stearas, pro compresso. - substitution en cas de dépendance aux opiacés - synthetika
subutex 8 mg sublingualtabletten
indivior schweiz ag - buprenorphinum - sublingualtabletten - buprenorphinum 8 mg ut buprenorphini hydrochloridum, lactosum monohydricum corresp. lactosum 182.165 mg, mannitolum, maydis amylum, povidonum k 30, acidum citricum, natrii citras dihydricus corresp. natrium 0.239 mg, magnesii stearas, pro compresso. - substitution en cas de dépendance aux opiacés - synthetika
suboxone 2 mg/0.5 mg sublingualtabletten
indivior schweiz ag - buprenorphinum, naloxonum - sublingualtabletten - buprenorphinum 2 mg ut buprenorphini hydrochloridum, naloxonum 0.5 mg ut naloxoni hydrochloridum dihydricum, lactosum monohydricum corresp. lactosum 41.87 mg, mannitolum, maydis amylum, povidonum k 30, acidum citricum, natrii citras dihydricus corresp. natrium 0.06 mg, aromatica (zitrone und limette) cum linaloolum et citralum et e 320, acesulfamum kalicum, magnesii stearas, pro compresso. - substitution en cas de dépendance aux opiacés - synthetika
suboxone 8 mg/2 mg sublingualtabletten
indivior schweiz ag - buprenorphinum, naloxonum - sublingualtabletten - buprenorphinum 8 mg ut buprenorphini hydrochloridum, naloxonum 2 mg ut naloxoni hydrochloridum dihydricum, lactosum monohydricum corresp. lactosum 167.5 mg, mannitolum, maydis amylum, povidonum k 30, acidum citricum, natrii citras dihydricus corresp. natrium 0.24 mg, aromatica (zitrone und limette) cum linaloolum et citralum et e 320, acesulfamum kalicum, magnesii stearas, pro compresso. - substitution en cas de dépendance aux opiacés - synthetika
temgesic 0,2 mg sublingualtabletten
eumedica pharmaceuticals ag - buprenorphinum - sublingualtabletten - buprenorphinum 0.2 mg ut buprenorphini hydrochloridum, lactosum monohydricum corresp. lactosum 28.349 mg, mannitolum, maydis amylum, povidonum k 30, acidum citricum, natrii citras dihydricus corresp. natrium 0.036 mg, magnesii stearas, pro compresso. - analgeticum - synthetika
temgesic 0,4 mg sublingualtabletten
eumedica pharmaceuticals ag - buprenorphinum - sublingualtabletten - buprenorphinum 0.4 mg ut buprenorphini hydrochloridum, lactosum monohydricum corresp. lactosum 28.144 mg, mannitolum, maydis amylum, povidonum k 30, acidum citricum, natrii citras dihydricus corresp. natrium 0.036 mg, magnesii stearas, pro compresso. - analgeticum - synthetika
subutex 100 mg depot-injektionslösung
indivior schweiz ag - buprenorphinum - depot-injektionslösung - buprenorphinum 100 mg, poly(lactidum-co-glycolidum) 50/50 (0.17 - 0.22 dl/g), n-methylpyrrolidonum, ad solutionem pro 0.5 ml. - substitution en cas de dépendance aux opiacés - synthetika
subutex 300 mg depot-injektionslösung
indivior schweiz ag - buprenorphinum - depot-injektionslösung - buprenorphinum 300 mg, poly(lactidum-co-glycolidum) 50/50 (0.17 - 0.22 dl/g), n-methylpyrrolidonum, ad solutionem pro 1.5 ml. - substitution en cas de dépendance aux opiacés - synthetika
temgesic solution injectable
eumedica pharmaceuticals ag - buprenorphinum - solution injectable - buprenorphinum 0.3 mg ut buprenorphini hydrochloridum, glucosum monohydricum, acidum hydrochloridum, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - analgésique - synthetika